Characterization of the homo‐ and heterotypic immune responses after natural norovirus infection

Noroviruses (NoV) are a genetically and antigenically diverse group of viruses that are common causes of outbreaks of gastroenteritis in humans of all ages. Limited information has been obtained on type specificity of the NoV immune response. In this study, we characterized the homologous and heterologous antibody responses in adults from 13 outbreaks, representing 4 different NoV genotypes. NoV specific IgG and IgA antibodies were determined as well as the increase of antibody avidity. In addition, antibody‐mediated blocking of NoV binding to its putative receptor was evaluated. Both homologous and heterologous serological responses were detected after NoV infection. The avidity of antibodies could not be used to distinguish between homologous and heterologous antibody responses. However, a homologous blocking response but not a heterologous response was detected after infection with NoV belonging to genogroup II.4 by a NoV ligand binding inhibition assay. Infection with NoV induces antibodies that can block virus ligand interactions. In contrast with all currently known antibody detection assays for NoV, this can be used as a type specific assay and may be an alternative for studying neutralizing antibodies. J. Med. Virol. 77:439–446, 2005. © 2005 Wiley‐Liss, Inc.

[1]  H. Vennema,et al.  Evidence of the etiological predominance of norovirus in gastroenteritis outbreaks—emerging new‐variant and recombinant noroviruses in Hungary , 2005, Journal of medical virology.

[2]  A. M. Hutson,et al.  Identification of Genogroup I and Genogroup II Broadly Reactive Epitopes on the Norovirus Capsid , 2005, Journal of Virology.

[3]  A. Rethwilm,et al.  Evidence of Recombination in the Norovirus Capsid Gene , 2005, Journal of Virology.

[4]  H. Vennema,et al.  Association of histo-blood group antigens and susceptibility to norovirus infections. , 2005, The Journal of infectious diseases.

[5]  R. Baric,et al.  Norovirus Capture with Histo-Blood Group Antigens Reveals Novel Virus-Ligand Interactions , 2004, Journal of Virology.

[6]  Harry Vennema,et al.  Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant , 2004, The Lancet.

[7]  M. Koopmans,et al.  Laboratory efforts to cultivate noroviruses. , 2004, The Journal of general virology.

[8]  I. Hickie,et al.  Measurement of EBV‐IgG anti‐VCA avidity aids the early and reliable diagnosis of primary EBV infection , 2003, Journal of medical virology.

[9]  M. Altaye,et al.  Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. , 2003, The Journal of infectious diseases.

[10]  N. Sakon,et al.  Precise Characterization of Norovirus (Norwalk-Like Virus)-Specific Monoclonal Antibodies with Broad Reactivity , 2003, Journal of Clinical Microbiology.

[11]  Xi Jiang,et al.  Human susceptibility and resistance to Norwalk virus infection , 2003, Nature Medicine.

[12]  M. Altaye,et al.  Homologous versus heterologous immune responses to Norwalk-like viruses among crew members after acute gastroenteritis outbreaks on 2 US Navy vessels. , 2003, The Journal of infectious diseases.

[13]  R. Baric,et al.  Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice , 2002, Journal of Virology.

[14]  A. Kanno,et al.  Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection , 2002, Journal of medical virology.

[15]  Harry Vennema,et al.  Natural history of human calicivirus infection: a prospective cohort study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Xi Jiang,et al.  Cross-Reactivity among Several Recombinant Calicivirus Virus-Like Particles (VLPs) with Monoclonal Antibodies Obtained from Mice Immunized Orally with One Type of VLP , 2002, Journal of Clinical Microbiology.

[17]  Y. V. van Duynhoven,et al.  Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. , 2001, American journal of epidemiology.

[18]  Y. V. van Duynhoven,et al.  Etiology of gastroenteritis in sentinel general practices in the netherlands. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Min-Shi Lee,et al.  Protective titres of measles neutralising antibody , 2000, Journal of medical virology.

[20]  S. Matsuura,et al.  Characterization of Monoclonal Antibodies Generated against Norwalk virus Gil Capsid Protein Expressed in Escherichia coli , 2000, Microbiology and immunology.

[21]  M. Estes,et al.  Taxonomy of the caliciviruses. , 2000, The Journal of infectious diseases.

[22]  D. Burton,et al.  Antibody and virus: binding and neutralization. , 2000, Virology.

[23]  Xi Jiang,et al.  Identification of an Epitope Common to Genogroup 1 “Norwalk-Like Viruses” , 2000, Journal of Clinical Microbiology.

[24]  Y. V. van Duynhoven,et al.  Molecular epidemiology of human enteric caliciviruses in The Netherlands. , 2000, The Journal of infectious diseases.

[25]  X. Jiang,et al.  Homotypic and heterotypic IgG and IgM antibody responses in adults infected with small round structured viruses , 1998, Journal of medical virology.

[26]  P. Payment,et al.  Prevalence of antibodies to the Hawaii strain of human calicivirus as measured by a recombinant protein based immunoassay , 1998, Journal of medical virology.

[27]  R. Glass,et al.  Correlation of patient immune responses with genetically characterized small round‐structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995 , 1997, Journal of medical virology.

[28]  J. Vinjé,et al.  The incidence and genetic variability of small round-structured viruses in outbreaks of gastroenteritis in The Netherlands. , 1997, The Journal of infectious diseases.

[29]  J. Vinjé,et al.  Molecular detection and epidemiology of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands. , 1996, The Journal of infectious diseases.

[30]  C. Maroto,et al.  Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review. , 1996, Microbios.

[31]  M. Estes,et al.  Antibody prevalence and immunoglobulin IgG subclass pattern to norwalk virus in Sweden , 1995, Journal of medical virology.

[32]  K. Dingle,et al.  Human enteric Caliciviridae: the complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus. , 1995, The Journal of general virology.

[33]  X. Jiang,et al.  Enzyme immunoassay using baculovirus‐expressed human calicivirus (Mexico) for the measurement of IgG responses and determining its seroprevalence in London, UK , 1995, Journal of medical virology.

[34]  L. Sawyer,et al.  Defining Surrogate Serologic Tests with Respect to Predicting Protective Vaccine Efficacy: Poliovirus Vaccination , 1995, Annals of the New York Academy of Sciences.

[35]  M. Estes,et al.  Seroprevalence studies using a recombinant norwalk virus protein enzyme immunoassay , 1994, Journal of medical virology.

[36]  M. Estes,et al.  Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations , 1993, Journal of clinical microbiology.

[37]  M. Estes,et al.  Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus , 1993, Journal of clinical microbiology.

[38]  D. Graham,et al.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein , 1992, Journal of virology.

[39]  J. Treanor,et al.  Antigenic relatedness among the Norwalk‐like agents by serum antibody rises , 1990, Journal of medical virology.

[40]  H. Dupont,et al.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. , 1990, The Journal of infectious diseases.

[41]  L. Anderson,et al.  Serum immunoglobulin A response to Norwalk virus infection , 1989, Journal of clinical microbiology.

[42]  K. Hedman,et al.  Measurement of avidity of specific IgG for verification of recent primary rubella , 1989, Journal of medical virology.

[43]  A. Vaheri,et al.  Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella , 1985, Journal of medical virology.

[44]  S. Inouye,et al.  Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed , 1984, Journal of clinical microbiology.

[45]  A. Kapikian,et al.  Clinical immunity in acute gastroenteritis caused by Norwalk agent. , 1977, The New England journal of medicine.

[46]  R. Chanock,et al.  Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. , 1974, The Journal of infectious diseases.